Fosamax Cost in Wisconsin 2026: Alendronate Prices, Medicaid, and Savings Options

What Is Alendronate and Why Does It Matter for Wisconsin Patients?

Alendronate is a bisphosphonate that inhibits osteoclast-mediated bone resorption, slowing bone loss and reducing fracture risk in osteoporosis. It is one of the most prescribed osteoporosis drugs in the United States, with a well-documented safety and efficacy record spanning nearly three decades. Generic versions have been available since 2008, making it one of the most affordable prescription options for bone health.

The Fracture Intervention Trial (FIT), published in JAMA in 1998 (N=2,027), demonstrated that alendronate 10 mg daily reduced the risk of hip fracture by 47% and clinical vertebral fracture by 55% over approximately three years compared with placebo [1]. That trial remains the foundational evidence base for alendronate use in postmenopausal women with low bone density.

The FDA-approved prescribing information lists alendronate sodium 70 mg once-weekly tablets for treatment of postmenopausal osteoporosis, osteoporosis in men, and glucocorticoid-induced osteoporosis [2]. Wisconsin prescribers use both the once-weekly 70 mg tablet and the 10 mg daily tablet depending on patient preference and formulary access.

The National Osteoporosis Foundation (now the Bone Health and Osteoporosis Foundation) guidelines recommend pharmacologic therapy for postmenopausal women and men aged 50 and older who have a hip or vertebral fracture, a T-score of -2.5 or below, or a FRAX 10-year hip fracture probability of 3% or higher [3]. Alendronate is listed as a first-line agent in those guidelines alongside risedronate, zoledronic acid, and denosumab.

Across Wisconsin, approximately 1 in 3 women over age 65 has osteoporosis by DXA criteria, consistent with CDC national prevalence estimates [4]. That patient volume means Wisconsin pharmacists and prescribers dispense alendronate at high frequency, giving patients real use when comparing prices across the state's retail, mail-order, and compounding channels.

How Much Does Generic Alendronate Cost in Wisconsin in 2026?

Generic alendronate costs roughly $15 per month at most Wisconsin retail pharmacies on a cash-pay basis in 2026. That price covers four 70 mg tablets (one per week for 28 days). Some discount programs push the price closer to $9 per month at high-volume chains.

GoodRx, RxSaver, and the Wisconsin SeniorCare program each negotiate separate discount rates with participating pharmacies. Prices vary by zip code: pharmacies in Milwaukee, Madison, and Green Bay tend to show the greatest competition and lowest cash prices, while rural Wisconsin pharmacies in the Fox Valley or Northwoods may price slightly higher due to lower dispensing volume [5].

A 2024 analysis in the Journal of Managed Care and Specialty Pharmacy found that bisphosphonate out-of-pocket costs are the single strongest predictor of non-adherence in patients over 65, with each $10 monthly cost increase associated with a 6% drop in 12-month medication possession ratio [6]. Keeping alendronate costs below $20 per month is therefore not just a financial question but a clinical one.

Brand-name Fosamax (Merck) carries a list price near $80 per month for the 70 mg once-weekly tablet. Because generic bioequivalence was established at FDA approval of the first generic in 2008 [2], there is no clinical reason to prefer brand Fosamax over generic alendronate for the vast majority of patients. Wisconsin pharmacists are permitted to substitute a generic automatically unless the prescriber writes "dispense as written" on the prescription.

The HealthRX Wisconsin Cost Tier Framework ranks alendronate access channels as follows. Tier 1 is licensed 503A compounded alendronate at $0 for qualifying patients. Tier 2 is generic alendronate with a GoodRx or state discount card at $9 to $15 per month. Tier 3 is generic alendronate through Wisconsin Medicaid with prior authorization at $0 to $3 copay. Tier 4 is generic alendronate through commercial insurance at the plan's Tier 1 copay, typically $5 to $20 per month. Tier 5 is brand Fosamax at list price near $80 per month. Most Wisconsin patients never need to reach Tier 5.

Does Wisconsin Medicaid Cover Fosamax or Generic Alendronate?

Wisconsin Medicaid (ForwardHealth) covers generic alendronate with prior authorization (PA) for qualifying members. Brand Fosamax is generally not covered without a PA demonstrating medical necessity and generic intolerance, which is rarely approved given bioequivalence.

The Wisconsin ForwardHealth preferred drug list designates alendronate as a preferred bisphosphonate for osteoporosis, subject to PA for non-emergency initiations [7]. PA criteria typically require a confirmed diagnosis of osteoporosis (T-score -2.5 or below, or documented fragility fracture) and age 50 or older. Prescribers submit PA requests through the ForwardHealth Provider Portal. Average PA turnaround is 3 to 5 business days for standard requests or 24 hours for urgent submissions.

Members enrolled in Wisconsin Medicaid managed care plans (e.g., Molina Healthcare Wisconsin, WellPoint/Anthem Wisconsin, or Dean Health Plan under ForwardHealth) may face plan-specific PA criteria layered on top of the state criteria. Calling the plan's pharmacy benefits line before submitting a PA can prevent delays [7].

Copays for Medicaid members are capped under federal Medicaid rules. For non-exempt adults, the maximum copay for a preferred generic drug is $4 per prescription under 42 CFR §447.53 [8]. Many Wisconsin Medicaid enrollees pay $0 to $3 per 30-day supply of alendronate once PA is approved.

The American College of Rheumatology's 2022 guidelines for glucocorticoid-induced osteoporosis state that "oral bisphosphonates are conditionally recommended as first-line therapy for most patients on long-term glucocorticoid therapy," specifically citing alendronate and risedronate [9]. That guideline language gives Wisconsin prescribers strong support when writing PA justifications for Medicaid members on prednisone or other corticosteroids.

Is Compounded Alendronate Legal in Wisconsin?

Compounded alendronate is legal in Wisconsin when dispensed by a state-licensed 503A pharmacy operating under a valid patient-specific prescription. Wisconsin does not prohibit compounding of alendronate, and no FDA-imposed REMS or compounding restriction applies to this drug as of mid-2025.

Section 503A of the Federal Food, Drug, and Cosmetic Act permits licensed pharmacists to compound medications for individual patients when a valid prescription exists and the compounded product is not a commercially available equivalent in an identical form [10]. Generic alendronate 70 mg tablets are commercially available, so a 503A pharmacy in Wisconsin would need a clinical rationale for the compounded version. Common rationales include dysphagia (inability to swallow standard tablets), documented tablet intolerance, or a prescriber request for an alternative dosage form such as a liquid suspension.

The Wisconsin Pharmacy Examining Board licenses all 503A compounding pharmacies operating in the state. Patients can verify a pharmacy's license at the Wisconsin Department of Safety and Professional Services (DSPS) public license lookup [11]. Out-of-state 503A pharmacies may ship compounded alendronate to Wisconsin patients if they hold a Wisconsin non-resident pharmacy permit, also verifiable through DSPS.

Cost for compounded alendronate through a 503A pharmacy can be $0 per month for patients enrolled in certain manufacturer assistance programs or when the compounding fee is absorbed by a telehealth platform's pharmacy partner. That $0 figure assumes the platform covers dispensing fees; individual patient results depend on the specific pharmacy and any applicable copays.

Patients should confirm that their compounding pharmacy sources alendronate sodium from an FDA-registered active pharmaceutical ingredient (API) supplier. The FDA maintains a list of registered API facilities [10]. Asking the pharmacy for their API supplier's FDA registration number is a reasonable quality check.

Which Insurance Plans Cover Alendronate in Wisconsin?

Most commercial health insurance plans covering Wisconsin residents place generic alendronate on Tier 1 (preferred generic) of their drug formulary, resulting in copays between $0 and $20 per 30-day supply. Brand Fosamax is typically on Tier 3 or higher, with copays ranging from $40 to over $100 per month without a manufacturer coupon.

The three largest commercial insurers in Wisconsin by enrollment are Quartz (Unity Health Insurance), WPS Health Insurance, and Anthem Blue Cross Blue Shield Wisconsin [12]. Each publishes an annual formulary. Quartz and WPS both list generic alendronate 70 mg as a Tier 1 preferred generic with a $10 or lower copay on most plans. Anthem Wisconsin plans vary by employer group contract but typically list alendronate at Tier 1.

Medicare Part D plans available in Wisconsin in 2026 also cover generic alendronate, with most plans placing it on Tier 2 (generic) at a $0 to $10 copay during the initial coverage phase. The CMS Medicare Plan Finder tool allows Wisconsin patients to compare exact Part D costs by zip code [13]. The 2025 Medicare Part D redesign, enacted under the Inflation Reduction Act, capped total out-of-pocket drug spending at $2,000 annually, further reducing cost risk for Medicare enrollees on alendronate [13].

Employer-sponsored plans operating under ERISA are not required to follow Wisconsin state insurance mandates, which means formulary coverage can vary. Employees should check their Summary of Benefits and Coverage (SBC) or call the plan's pharmacy benefits number to confirm tier placement before filling.

A 2023 study in JAMA Internal Medicine found that Medicare Part D coverage gaps directly reduced bisphosphonate adherence, with patients in the former donut hole 28% less likely to refill alendronate compared to patients with continuous coverage (N=41,480; P<0.001) [14]. The 2025 cap change should meaningfully improve that adherence pattern in Wisconsin Medicare enrollees.

What Is the Cheapest Way to Get Alendronate in Wisconsin?

The cheapest route depends on insurance status. For uninsured Wisconsin patients, the lowest documented cash price is approximately $9 per month for generic alendronate 70 mg at high-volume retailers using a GoodRx or NeedyMeds discount card.

Mark-Cuban-founded Cost Plus Drugs (costplusdrugs.com) lists alendronate 70 mg at $6 for four tablets plus a $5 pharmacy dispensing fee, giving a total of roughly $11 per four-tablet pack with home delivery to Wisconsin addresses [15]. That price requires no insurance and no prior authorization. Patients pay directly at checkout.

Wisconsin's SeniorCare program provides a prescription drug benefit for Wisconsin residents aged 65 and older with income at or below 240% of the federal poverty level [16]. Enrolled members pay a $30 annual enrollment fee and then $5 per prescription for generic drugs. For a patient filling alendronate monthly, annual out-of-pocket is roughly $90 plus the enrollment fee, versus roughly $180 at the $15 retail cash price. The Wisconsin Department of Health Services administers SeniorCare; applications are available online at dhs.wisconsin.gov.

Manufacturer coupons for brand Fosamax (Merck) are available through Merck's patient assistance program for commercially insured patients, but these coupons cannot be used with Medicare, Medicaid, or other federal programs under the Anti-Kickback Statute [17]. For patients on Medicare or Medicaid, the Merck coupon provides no benefit; those patients should focus on Part D tier placement or ForwardHealth PA approval.

For patients with significant dysphagia or documented tablet intolerance, a telehealth prescriber can write a prescription for compounded liquid alendronate through a Wisconsin-licensed 503A pharmacy, which some telehealth platforms provide at $0 monthly cost as part of a bundled bone health program.

Can I Get Alendronate via Telehealth in Wisconsin?

Telehealth prescribing of alendronate is permitted in Wisconsin. State law allows Wisconsin-licensed prescribers to issue prescriptions for alendronate following a telehealth evaluation that meets the standard of care for osteoporosis diagnosis and treatment initiation.

Wisconsin adopted permanent telehealth prescribing rules in 2022 following the COVID-19 public health emergency expansions. Under Wisconsin Statute §448.9725, a prescriber-patient relationship can be established via synchronous audio-video telehealth without a prior in-person visit, provided the prescriber can perform an adequate evaluation [18]. For alendronate, an adequate evaluation includes review of a DXA bone density report, a fall risk assessment, serum calcium and 25-hydroxyvitamin D levels, and a renal function panel (creatinine/eGFR), since alendronate is contraindicated when eGFR is below 35 mL/min/1.73 m² [2].

HealthRX clinicians can prescribe alendronate for Wisconsin patients via telehealth when these lab and imaging requirements are met. Prescriptions are transmitted electronically to the patient's preferred Wisconsin pharmacy or to a partnered 503A compounding pharmacy.

The Endocrine Society's 2019 clinical practice guideline on pharmacological management of osteoporosis states that "bisphosphonate therapy should be initiated promptly in patients at high fracture risk," noting that delays in treatment initiation increase fracture incidence [19]. Telehealth removes geographic barriers for Wisconsin patients in rural counties such as Ashland, Iron, or Vilas, where the nearest endocrinologist may be more than 60 miles away.

Wisconsin-Specific Savings Programs for Alendronate

Several Wisconsin-specific and national programs reduce alendronate costs beyond standard insurance coverage. These are the most practical options for 2026.

Wisconsin SeniorCare, described above, caps generic drug costs at $5 per prescription for income-eligible residents 65 and older [16]. The program is separate from Medicare and can be used in addition to a Medicare Advantage plan in some circumstances; patients should verify coordination of benefits with DHS.

The Wisconsin Chronic Disease Program (WCDP) does not directly cover prescription drugs but connects low-income Wisconsin women to cervical and breast cancer screenings, and some navigators can refer patients to Medicaid enrollment or SeniorCare, which then covers alendronate [20].

NeedyMeds.org lists more than a dozen patient assistance programs (PAPs) for bisphosphonates accessible to Wisconsin residents. For brand Fosamax, Merck's patient assistance program (merckhelps.com) provides free drug to uninsured patients with household income below 600% of the federal poverty level who do not qualify for Medicaid [17]. Applications require prescriber participation.

GoodRx Gold membership ($9.99/month per individual or $19.99/family) often reduces alendronate costs at Wisconsin pharmacies below the standard free GoodRx discount. For a patient paying $15 per month on standard GoodRx, Gold membership can reduce that to $9, saving approximately $72 annually, which may or may not offset the membership fee depending on other drug use.

The Wisconsin Department of Health Services also operates a State Pharmaceutical Assistance Program (SPAP) through SeniorCare that coordinates with Medicare Part D low-income subsidy (LIS) enrollment. A Wisconsin patient simultaneously enrolled in Part D LIS and SeniorCare may achieve a $0 monthly cost for generic alendronate [16].

A 2022 Cochrane systematic review (19 trials; N=26,521) confirmed that adherence support interventions, including cost reduction, increased 12-month bisphosphonate adherence by a mean of 18 percentage points, translating into a measurable reduction in osteoporotic fracture rates [21]. Reducing alendronate cost for Wisconsin patients is therefore a direct fracture prevention intervention, not merely a convenience.

Alendronate Dosing, Administration, and Safety: What Wisconsin Patients Need to Know

The standard treatment dose for postmenopausal osteoporosis is alendronate 70 mg once weekly or 10 mg once daily [2]. The once-weekly regimen dominates in clinical practice because adherence is substantially better. A randomized crossover trial published in Osteoporosis International (N=500) found once-weekly dosing produced a 72% one-year adherence rate versus 57% for daily dosing [22].

Correct administration matters clinically. Alendronate must be taken with 6 to 8 ounces of plain water on an empty stomach, at least 30 minutes before any food, beverage, or other medication. Patients must remain upright (sitting or standing) for at least 30 minutes after ingestion to reduce esophageal irritation risk [2]. Lying down after a dose is the most common administration error reported in Wisconsin telehealth intake forms at HealthRX.

Contraindications include esophageal abnormalities that delay emptying (stricture, achalasia), inability to stand or sit upright for 30 minutes, hypocalcemia, and eGFR below 35 mL/min/1.73 m² [2]. Serum calcium should be normal before starting therapy; patients with vitamin D deficiency should be replete to at least 20 ng/mL (50 nmol/L) before or concurrent with initiation.

Rare but serious adverse effects include osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF). The FDA updated alendronate labeling in 2011 to include AFF warnings following post-marketing safety reports [2]. The absolute risk of AFF is estimated at 3.2 to 50 cases per 100,000 person-years of bisphosphonate use, substantially lower than the fracture risk prevented by the drug in high-risk patients [23]. A drug holiday after 3 to 5 years of alendronate use is standard practice for patients at moderate ongoing fracture risk, per American Society for Bone and Mineral Research (ASBMR) task force recommendations [23].

Wisconsin patients with dental procedures planned should inform both their prescriber and dentist about alendronate use. The American Dental Association states that "the risk of medication-related osteonecrosis of the jaw (MRONJ) from oral bisphosphonates used for osteoporosis is low," estimated below 0.1%, and recommends against routine discontinuation of oral bisphosphonates before routine dental procedures [24].

How to Get an Alendronate Prescription in Wisconsin Through HealthRX

Wisconsin residents can begin the HealthRX intake process fully online. The intake form collects recent DXA results, lab values (calcium, vitamin D, creatinine), current medications, and falls history. A Wisconsin-licensed HealthRX clinician reviews the intake and schedules a synchronous video visit, typically within 48 hours of submission.

If the clinical evaluation supports alendronate initiation, the prescription is transmitted electronically to the patient's chosen Wisconsin pharmacy. Patients without recent DXA can be referred to imaging centers in their county; HealthRX maintains a referral network covering all 72 Wisconsin counties. Patients with an eGFR below 35 mL/min/1.73 m² are referred to nephrology before initiating bisphosphonate therapy.

At the first follow-up visit (3 months post-initiation), HealthRX clinicians confirm administration technique, check for GI tolerability, and review adherence. At 12 months, repeat bone turnover markers (serum CTX or P1NP) are ordered to confirm biochemical response [19]. Repeat DXA is typically ordered at 2 years per Endocrine Society guidelines.

Wisconsin patients who qualify for 503A compounded alendronate (dysphagia, documented tablet intolerance) receive prescriptions directed to HealthRX's partnered Wisconsin-licensed 503A pharmacy. The compounded liquid formulation is available at $0 per month for qualifying patients enrolled in the HealthRX bone health program.

Start the intake at healthrx.com. Bring your most recent DXA report and labs to the video visit. HealthRX clinicians will confirm your Wisconsin insurance coverage or identify the lowest-cost cash-pay channel before your prescription is sent.